Last Updated: August 9, 2026

Litigation Details for LEO Pharma A/S v. Glenmark Pharmaceuticals Ltd. (D. Del. 2020)


✉ Email this page to a colleague

« Back to Dashboard


LEO Pharma A/S v. Glenmark Pharmaceuticals Ltd. (D. Del. 2020)

Docket ⤷  Start Trial Date Filed 2020-10-07
Court District Court, D. Delaware Date Terminated 2022-04-25
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To Jennifer L. Hall
Parties LEO PHARMA, INC.
Patents 10,130,640; 10,617,698; 10,660,908; 10,682,364; 10,688,108; 10,716,799; 9,119,781; 9,566,286
Attorneys Matthew V. Anderson
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in LEO Pharma A/S v. Glenmark Pharmaceuticals Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Details for LEO Pharma A/S v. Glenmark Pharmaceuticals Ltd. (D. Del. 2020)

Glossary
Date Filed Document No. Description Snippet Link To Document
2020-10-07 External link to document
2020-10-07 11 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,119,781 ;9,566,286 ;10,130,640 . (Gattuso…2020 25 April 2022 1:20-cv-01359 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2020-10-07 149 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,617,698 B2 ;10,660,908 B2 …2020 25 April 2022 1:20-cv-01359 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2020-10-07 4 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,617,698 B2 ;10,660,908 B2 …2020 25 April 2022 1:20-cv-01359 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links